To inspire and empower millions of people living with Parkinson’s around the world, Bial launches a touching campaign for the World Parkinson’s Day showing that it is possible to live a normal life, and successfully perform everyday tasks
Imagine being unable to control your own body. In your mind, everything is exactly like it was; but your brain seems to have forgotten how to tell your body to do everyday tasks like tying up shoes or using a toothbrush.
This is how it feels to live with Parkinson’s. A real challenge for the 10 million people diagnosed with Parkinson’s around the world. Parkinson’s is a progressive neurodegenerative disease – an illness that affects nerve cells in the brain. For those who live with these symptoms and for their families, Parkinson’s means much more than just physical symptoms: it also means a loss of their independence.
In order to raise awareness and help people keep their self-esteem, people with Parkinson’s were invited to star in a video that shows them at their best by focusing on what they can do instead of what they cannot do. Buttoning up shirts, putting on make-up, tying up shoes or even dancing and playing musical instruments. Simple, everyday tasks alongside a cheerful, feel-good tune developed specially for the campaign.
António Portela, CEO of Bial, explains the positive tone of the campaign: “Parkinson’s can really change people’s lives, but it’s very important that they do not lose their self-esteem. That is why we wanted to counter the negative portraits of people with Parkinson’s and show everyone what they really can do. Hopefully, we can inspire and empower the millions of people living with Parkinson’s to never give up on their dignity. Bial’s aim is to help the lives of people with Parkinson’s even if it’s to help with one small thing at a time.”
The campaign launches worldwide today – on World Parkinson’s Day – and is featured on Bial’s website, across Bial’s social media and on the European Parkinson’s Disease Association’s social media channels too.
Watch the video ‘Me at my best’ below
This article is sponsored by Bial. The information in this article is given for information purposes only and does not represent an endorsement by the EPDA of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided.
Founded in 1924, Bial’s mission is to discover, develop and provide therapeutic solutions within the area of health. In recent decades, Bial has strategically focused on quality, innovation and internationalisation. Bial has channelled more than 20% of its annual turnover into research and development within neurosciences and the cardiovascular system.
In 2016 Bial launched Opicapone for Parkinson’s disease. Already available in Germany and in the United Kingdom, it will be introduced in the remaining European countries throughout 2017.
Currently representing around two thirds of its turnover, Bial will continue to strengthen its international presence based in its own innovative medicines, particularly in the most important European pharmaceutical markets, Spain, Germany, United Kingdom and Italy, where the company is already present with its own affiliates. For more information about Bial, please visit www.bial.com.
My PD Journey: landmark Parkinson’s summit highlights urgent need for new composite scale
European coalition set to roll out new and simple composite scale
7 days ago
Better balanced immune system could prevent Parkinson’s
A study, published in the journal ‘Nature’, has suggested that it may be possible to prevent Parkinson’s disease by balancing the immune system. The research, which studied 103 participants, found that Parkinson’s could be an autoimmune disease – a condition which leads the body’s immune system to attack healthy cells. David Sulzer, a professor at the Columbia University Medical Center, New York, US, who led the study, said: “The idea that a malfunctioning immune system contributes to Parkinson’s dates back almost 100 years. But until now, no one has been able to connect the dots. Our findings show that two fragments of alpha-synuclein, a protein that accumulates in the brain cells of people with Parkinson’s, can activate the T cells involved in autoimmune attacks”. The team believe that neurons in those with Parkinson’s are not able to get rid of alpha-synuclein, leading to their proteins being mistaken for a virus…
Scottish Parkinson’s support group awarded £60,000 from Big Lottery Fund
The Big Lottery Fund has donated £60,000 to a Parkinson’s self-help group in Airdrie, Scotland. The organisation will use the funds to support local residents who are living with Parkinson’s. A Lottery spokesperson commented: “By offering a central meeting space and a programme of activities, the organisation will support people, families and carers to feel less isolated and encourage them to support each other, to better cope with the effects of the illness and the impact it has on their lives.” A Parkinson’s self-help spokesperson said: “Among other things, these funds will help us secure staff salaries as well as costs for therapists. “We will be working very closely with the Big Lottery Fund over the next year to help secure the group for years to come. We want to thank members for all of their support and hard work.” Image credit: Tom Dick/Media Scotland
Indian university launches first Parkinson’s programme
India’s first multidisciplinary movement disorder programme, specifically for the treatment of Parkinson’s disease, has been launched. The programme, which is based at the Sri Venkateswara Institute of Medical Sciences, Andhra Pradesh, India will bring together neurologists, neurosurgeons, psychiatrists and other healthcare professionals to treat those living with the condition. Dr T S Ravi Kumar, vice chancellor at the Sri Venkateswara Institute of Medical Sciences, said: “To date, the state did not have a dedicated programme to attack this problem in a comprehensive way. In order to mitigate this disabling set of conditions, we have launched the programme.” The programme will offer a range of Parkinson’s treatments including complementary therapies and yoga classes to help manage symptoms. Last month, the institute performed its first deep brain stimulation procedure on a patient with Parkinson’s.